Filing Details
- Accession Number:
- 0001213900-21-060526
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-11-18 15:44:50
- Reporting Period:
- 2021-11-15
- Accepted Time:
- 2021-11-18 15:44:50
- Original Submission Date:
- 2021-11-15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533030 | Cryomass Technologies Inc. | CRYM | Cutlery, Handtools & General Hardware (3420) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1809272 | Hannes Delon Human | 1001 Bannock Street, Suite 612 Denver CO 80204 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-11-15 | 760,000 | $0.20 | 760,000 | No | 4 | P | Indirect | By Health Diplomats Pte Ltd |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Health Diplomats Pte Ltd |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2021-11-15 | 760,000 | $0.00 | 760,000 | $0.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,260,000 | 2021-11-15 | 2023-11-15 | No | 4 | P | Indirect |
Footnotes
- Health Diplomats Pte Ltd is a Singapore exempt private company limited by shares 100% owned by Mr. Human.
- The purchase reflects a Unit purchase, each Unit consisting of (a) 10,000 shares of common stock at a price of $0.20 per share and (b) one common stock purchase warrant exercisable to purchase 10,000 additional shares of common stock of the corporation (each such additional share a "Warrant Share") at an exercise price of $0.40 per Warrant Share. For the purposes of this report no purchase price has been attributed to the warrant.